Skip to main content
Fig. 7 | Journal of Experimental & Clinical Cancer Research

Fig. 7

From: EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches

Fig. 7

EZH2 modulation in Jurkat. (a) EZH2 expression evaluated through real time PCR in Jurkat at 48 and 72 h after treatment with Dauno, DZNep and Dauno + DZNep. (b) EZH2 expression evaluated through immunoblotting in Jurkat cell line treated at 48 h with Dauno, DZNep and Dauno + DZNep. The experiments were repeated three times and the values are the mean ± SD of the three independent experiments

Back to article page